| 24.05. | BB BIOTECH AG : Disruptive technologies are changing an entire industry |  |
| 19.05. | BIOTECH : Keller (Bb Biotech), continua a crescere nonostante incertezza |  |
| 22.04. | BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 22.04. | BB Biotech Swings To Q1 Loss As Total Returns Plummet | |
| 22.04. | BB Biotech plombé au 1er trimestre par des marchés capricieux |  |
| 22.04. | BB BIOTECH : Rapporto intermedio al 31 marzo 2022 | |
| 22.04. | BB BIOTECH : Relazione finaziaria | |
| 22.04. | BB Biotech AG pubblica il proprio rapporto intermedio | |
| 22.04. | BB Biotech AG publishes its interim report | |
| 22.04. | BB BIOTECH AG : Increased investment level balanced by established core holdings | |
| 22.04. | BB BIOTECH AG : Posizioni principali affermate consentono un maggiore grado d'investimento | |
| 21.04. | L'agenda di domani | |
| 21.04. | L'agenda della settimana | |
| 20.04. | BOLSA DE MADRID : El Nasdaq rebota, Netflix se hunde |  |
| 20.04. | Le Nasdaq se rebiffe, Netflix coule | |
| 20.04. | AVIS D'ANALYSTES DU JOUR : Thales, Dassault Aviation, Leonardo, Ericsson, Virbac, Givaudan.. | |
| 19.04. | BB BIOTECH : Keller, grandi opportunita' per settore biotech | |
| 19.04. | L'agenda della settimana | |
| 14.04. | L'agenda della prossima settimana | |
| 12.04. | GLOBAL MARKETS LIVE : Honda, Shopify, Meta, ASOS, Gilead Sciences... | |
| 12.04. | BOURSE ZURICH : le SMI ancré dans le rouge en attendant l'inflation US | |
| 12.04. | BB Biotech Launches New Share Repurchase Program | |
| 12.04. | BOLA DE MADRID : El pueblo galo resiste | |
| 12.04. | Le village gaulois | |
| 12.04. | BOURSE ZURICH : repli attendu sur fond d'escalade des taux US | |
| 12.04. | EN DIRECT DES MARCHES : AXA, EssilorLuxottica, TotalEnergies, bioMérieux, Givaudan, Sika, .. | |
| 12.04. | BB Biotech boucle son programme de rachat d'actions et en lance un nouveau | |
| 12.04. | BB Biotech AG concludes its share buyback program and launches a new buyback program | |
| 12.04. | BB Biotech AG announces an Equity Buyback. | |
| 12.04. | Tranche Update on BB Biotech AG’s Equity Buyback Plan announced on April 11, 2019. | |
| 12.04. | BB Biotech AG authorizes a Buyback Plan. | |
| 11.04. | BB Biotech AG's Equity Buyback announced on April 12, 2019, has expired with 0 shares, .. | |
| 30.03. | IREN : Standard Ethics conferma il rating | |
| 22.03. | BORSA I. : riprende in presenza la Star Conference 2022 | |
| 21.03. | Principales informations avant-Bourse | |
| 18.03. | Principales informations avant-Bourse | |
| 17.03. | In occasione dell'Assemblea generale annuale di BB Biotech AG gli azionisti hanno votat.. | |
| 17.03. | Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividen.. | |
| 17.03. | Bb Biotech Ag Approves Dividend , Payable on March 23,2022 | |
| 17.03. | BB Biotech AG Announces Board Elections | |
| 19.02. | Tranche Update on BB Biotech AG’s Equity Buyback Plan announced on April 11, 2019. | |
| 19.02. | BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 18.02. | BB Biotech; in 2021 perdita netta di 405 mln chf, dividendo a 3,85 chf/azione | |
| 18.02. | BB BIOTECH : conferma dividendo ordinario a 3,85 chf/azione | |
| 18.02. | BB BIOTECH : Esg | |
| 18.02. | BB BIOTECH : in 2021 perdita netta di 405 mln chf (utile di 691 mln chf in 2020) | |
| 18.02. | Principales informations avant-Bourse | |
| 18.02. | BB Biotech AG publishes its 2021 annual report | |
| 18.02. | L'agenda di oggi | |
| 18.02. | BB Biotech Swings To FY21 Loss On Higher Operating Expenses | |
| 18.02. | BB biotech confirme sa perte subie en 2021, mais aussi le dividende | |
| 18.02. | BB BIOTECH : Business report | |
| 18.02. | BB BIOTECH : Corporate Governance | |
| 18.02. | BB BIOTECH : Remuneration Report | |
| 18.02. | BB BIOTECH : Relazione della società | |
| 18.02. | BB BIOTECH : Relazione sulle retribuzioni | |
| 18.02. | BB Biotech AG publishes its 2021 annual report | |
| 18.02. | BB Biotech AG pubblica il rapporto annuale 2021 | |
| 16.02. | L'agenda della settimana | |
| 14.02. | L'agenda della settimana | |
| 11.02. | L'agenda della prossima settimana | |
| 01.02. | Xlife Sciences cotée sur SIX à partir du 11 février prochain | |
| 21.01. | BB BIOTECH : chiude 2021 con una perdita di 405 mln di chf | |
| 21.01. | BB BIOTECH : chiude 2021 con perdita di 405 mln chf | |
| 21.01. | Principales informations avant-Bourse | |
| 21.01. | BB Biotech boucle l'année 2021 sur une perte | |
| 21.01. | BB Biotech Forecasts Switch to FY21 Loss in 'Difficult Year' | |
| 21.01. | BB Biotech AG registra una perdita al termine dell'esercizio 2021 | |
| 21.01. | BB Biotech AG closes the 2021 fiscal year with a loss | |
| 21.01. | BB BIOTECH AG : 2021 was a difficult year for biotech equity markets - increased dividend .. | |
| 21.01. | BB BIOTECH AG : Un difficile 2021 per i titoli biotecnologici - Proposto un aumento del di.. | |
| 21.01. | BB Biotech AG Proposes a Regular Dividend | |
| 2021 | BORSA : Milano -1,22%, WS in calo | |
| 2021 | BB BIOTECH : «Cancer medicine improves the chances of a cure» | |
| 2021 | BB Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended Sept.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
